Xcout Intel
Faeth Therapeutics, Inc.
Faeth Therapeutics is a clinical-stage biotechnology company pioneering multi-node inhibition of the PI3K/AKT/mTOR pathway, which is the most frequently altered oncogenic pathway in cancer.
Subscribe to see Faeth Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Faeth Therapeutics, Inc. at a glance
Faeth Therapeutics, Inc. is a drug discovery company headquartered in Rockville, United States. It is publicly listed (FTH) with a market capitalisation of $496.1M. Xcout tracks 23 named people at Faeth Therapeutics, Inc., including Anand Parikh (CEO, President & Chair). Xcout recorded 9 job postings from Faeth Therapeutics, Inc. in the last 90 days.
Faeth Therapeutics, Inc. leadership
- Anand ParikhCEO, President & Chair
- Oliver MaddocksCo-Founder & Chief Scientific Officer
- Karen H. VousdenScientific Co-Founder & Director
- Benjamin HopkinsScientific Co-Founder
- Gregory J. HannonScientific Co-Founder
- Lewis Clayton CantleyScientific Co-Founder
17 more named people on record for Faeth Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Faeth Therapeutics, Inc.
Xcout recorded 9 job postings from Faeth Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Faeth Therapeutics, Inc.'s hiring signals →
Investors
Faeth Therapeutics, Inc. competitors
A few of Faeth Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's research focuses on restoring health and curing diseases that currently lack effective treatment options.
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Allosteros Therapeutics, Inc. is a biotechnology company headquartered in Palo Alto, California, engaged in the discovery and development of small molecule drugs. The company focuses on creating novel, potent, and selective therapeutics designed to target key proteins in cardiovascular disease signaling pathways.
Structure Therapeutics is a science-driven, clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule and peptide therapeutics to treat chronic metabolic and pulmonary diseases.
Conforma Therapeutics was a biotechnology company focused on discovering and developing small-molecule cancer therapeutics, particularly kinase inhibitors. Biogen Idec acquired the company in 2006 to obtain its oncology drug-discovery programs.
Get Faeth Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Faeth Therapeutics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Faeth Therapeutics, Inc. in Xcout Intel
- 23 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access